483 HomeChoice Partners dba Bioscrip Infusion Services Sep 2018

483 HomeChoice Partners dba Bioscrip Infusion Services Sep 2018

Tiara Brown-Crosen FDA$119.00 - Available Now

FDA investigators audited the HomeChoice Partners dba Bioscrip Infusion Services - Chesterfield, MO, United States facility and issued inspectional observations (via FDA 483) on 19 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Sep 2018
  • Location: Chesterfield, United States
  • FEI: 3014088548
Add To Cart